Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-21

FDA Approved: INBRIJA — Original Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved INBRIJA (levodopa inhalation powder) under an original application from Merz Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INBRIJA (levodopa inhalation powder)

Snippet

ORIG AP for INBRIJA (LEVODOPA)